Clinical Research: Phase 1 - Phase 4

A Primer on Cancer Immunotherapy Part 2: The Cancer Immune Response & Mechanisms of Resistance

Immunotherapy has led to substantial advances in cancer therapy in recent years. Still, unpredictable response rates and immune-related adverse events have hampered the widespread use of immune checkpoint therapy to treat cancers. To tackle these challenges, sponsors are increasingly looking to combination therapies as a strategy for improving response and overcoming resistance. In our previous...